MYRIAD GENETICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.31 USD | +2.84% |
|
-0.63% | +32.24% |
| 13/05 | Piper Sandler Adjusts Price Target on Myriad Genetics to $28 From $23, Maintains Neutral Rating | MT |
| 08/05 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MYRIAD GENETICS, INC. | Diagnostic & Testing Substances | +2.84% | -0.63% | +32.24% | +34.84% | -2.65% | 228.89Cr |  | | |
- Stock Market
- Equities
- MYGN Stock
- Charts Myriad Genetics, Inc.
- Relative Strength Chart
